|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||
| Accounts receivable - net of allowance for doubtful accounts | ||||||||||||
| Prepaid and other current assets | ||||||||||||
| Total current assets | ||||||||||||
| Fixed assets, net | ||||||||||||
| Employee incentive mortgages | ||||||||||||
| Total | ||||||||||||
| Total other assets | ||||||||||||
| Less: Accumulated Depreciation | ||||||||||||
| Less accumulated depreciation | ||||||||||||
| Total assets | ||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||
| Current liabilities: | ||||||||||||
| Accrued expenses | ||||||||||||
| Factored accounts receivable liability | ||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||
| Loans payable - insurance | ||||||||||||
| Federal and State Taxes Payable | ||||||||||||
| Loans payable - equipment | ||||||||||||
| Loans payable - equipment, related party - current | ||||||||||||
| Notes payable - related party, net of debt discount of $206,834 at March 31, 2023 | ||||||||||||
| Loans payable - equipment, related party | ||||||||||||
| Notes payable - related party, net of debt discount of $137,889 at June 30, 2023 | ||||||||||||
| Convertible notes payable, net of debt discount of $650,259 at June 30, 2023 and $1,030,041 at September 30, 2022 | ||||||||||||
| Convertible note payable - accrued interest | ||||||||||||
| Operating lease liability | ||||||||||||
| Finance lease liability | ||||||||||||
| Loan payable | ||||||||||||
| Notes payable, net (Note 10) | ||||||||||||
| Convertible notes, net (Note _) | ||||||||||||
| Total current liabilities | ||||||||||||
| Loan payable - stockholder | ||||||||||||
| Loan payable stockholder | ||||||||||||
| Loan payable - other (Note 10) | ||||||||||||
| Note payable, net (Note 10) | ||||||||||||
| Long-term liabilities: | ||||||||||||
| Operating lease liability - non-current | ||||||||||||
| Loan payable - related party | ||||||||||||
| Convertible notes, net payable | ||||||||||||
| Convertible note payable - accrued interest | ||||||||||||
| Finance lease liability - non-current | ||||||||||||
| Notes payable - related party, net of debt discount of $192,000 at September 30, 2022 | ||||||||||||
| Operating lease liability | ||||||||||||
| Finance lease liability | ||||||||||||
| Loans payable - equipment | ||||||||||||
| Loans payable - equipment, related party | ||||||||||||
| Loans payable - stockholder | ||||||||||||
| Total other liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Stockholders' deficit: | ||||||||||||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2023 and September 30, 2022 | ||||||||||||
| Common stock, $0.001 par value, 75,000,000 shares authorized, 15,784,424 and 15,764,424 shares issued and outstanding as of June 30, 2023 and September 30, 2022, respectively | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total stockholders' deficit | ||||||||||||
| Total liabilities and stockholders' deficit |
Loading...
